Non-micronized and micronized curcumin do not prevent the behavioral and neurochemical effects induced by acute stress in zebrafish.
Acute restraint stress
Curcumin
Open tank test
Oxidative damage
Zebrafish
Journal
Pharmacological reports : PR
ISSN: 2299-5684
Titre abrégé: Pharmacol Rep
Pays: Switzerland
ID NLM: 101234999
Informations de publication
Date de publication:
Aug 2022
Aug 2022
Historique:
received:
29
04
2022
accepted:
06
07
2022
revised:
16
06
2022
pubmed:
20
7
2022
medline:
6
8
2022
entrez:
19
7
2022
Statut:
ppublish
Résumé
Curcumin, a polyphenol extracted from the rhizome of Curcuma longa L. (Zingiberaceae), presents neuroprotective properties and can modulate neuronal pathways related to mental disorders. However, curcumin has low bioavailability, which can compromise its use. The micronization process can reduce mean particle diameter and improve this compound's bioavailability and therapeutic potential. We compared the behavioral (open tank test, OTT) and neurochemical (thiobarbituric acid reactive substances (TBARS) and non-protein thiols (NPSH) levels) effects of non-micronized curcumin (CUR, 10 mg/kg, ip) and micronized curcumin (MC, 10 mg/kg, ip) in adult zebrafish subjected to a 90-min acute restraint stress (ARS) protocol. ARS increased the time spent in the central area and the number of crossings and decreased the immobility time of the animals in the OTT. These results suggest an increase in locomotor activity and a decrease in thigmotaxis behavior. Both CUR and MC were not able to prevent these effects. Furthermore, ARS also induced oxidative damage by increasing TBARS and decreasing NPSH levels. Both CUR and MC did not prevent these effects. ARS-induced behavioral and biochemical effects were not blocked by any curcumin preparation. Therefore, we conclude that curcumin does not have acute anti-stress effects in zebrafish.
Sections du résumé
BACKGROUND
BACKGROUND
Curcumin, a polyphenol extracted from the rhizome of Curcuma longa L. (Zingiberaceae), presents neuroprotective properties and can modulate neuronal pathways related to mental disorders. However, curcumin has low bioavailability, which can compromise its use. The micronization process can reduce mean particle diameter and improve this compound's bioavailability and therapeutic potential.
METHODS
METHODS
We compared the behavioral (open tank test, OTT) and neurochemical (thiobarbituric acid reactive substances (TBARS) and non-protein thiols (NPSH) levels) effects of non-micronized curcumin (CUR, 10 mg/kg, ip) and micronized curcumin (MC, 10 mg/kg, ip) in adult zebrafish subjected to a 90-min acute restraint stress (ARS) protocol.
RESULTS
RESULTS
ARS increased the time spent in the central area and the number of crossings and decreased the immobility time of the animals in the OTT. These results suggest an increase in locomotor activity and a decrease in thigmotaxis behavior. Both CUR and MC were not able to prevent these effects. Furthermore, ARS also induced oxidative damage by increasing TBARS and decreasing NPSH levels. Both CUR and MC did not prevent these effects.
CONCLUSION
CONCLUSIONS
ARS-induced behavioral and biochemical effects were not blocked by any curcumin preparation. Therefore, we conclude that curcumin does not have acute anti-stress effects in zebrafish.
Identifiants
pubmed: 35852770
doi: 10.1007/s43440-022-00389-6
pii: 10.1007/s43440-022-00389-6
doi:
Substances chimiques
Antioxidants
0
Thiobarbituric Acid Reactive Substances
0
Curcumin
IT942ZTH98
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
736-744Informations de copyright
© 2022. The Author(s) under exclusive licence to Maj Institute of Pharmacology Polish Academy of Sciences.
Références
Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009;10:397–409.
pubmed: 19469025
pmcid: 4240627
doi: 10.1038/nrn2647
Chattarji S, Tomar A, Suvrathan A, Ghosh S, Rahman MM. Neighborhood matters: divergent patterns of stress-induced plasticity across the brain. Nat Neurosci. 2015;18:1364–75.
pubmed: 26404711
doi: 10.1038/nn.4115
McEwen BS, Bowles NP, Gray JD, Hill MN, Hunter RG, Karatsoreos IN, et al. Mechanisms of stress in the brain. Nat Neurosci. 2015;18:1353–63.
pubmed: 26404710
pmcid: 4933289
doi: 10.1038/nn.4086
McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873–904.
pubmed: 17615391
doi: 10.1152/physrev.00041.2006
Joëls M, Baram TZ. The neuro-symphony of stress. Nat Rev Neurosci. 2009;10:459–66.
pubmed: 19339973
pmcid: 2844123
doi: 10.1038/nrn2632
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.
pubmed: 26711676
pmcid: 5542678
doi: 10.1038/nri.2015.5
Ramaholimihaso T, Bouazzaoui F, Kaladjian A. Curcumin in depression: potential mechanisms of action and current evidence-a narrative review. Front Psychiatry. 2020;11: 572533.
pubmed: 33329109
pmcid: 7728608
doi: 10.3389/fpsyt.2020.572533
Avery SV. Molecular targets of oxidative stress. Biochem J. 2011;434:201–10.
pubmed: 21309749
doi: 10.1042/BJ20101695
Picard M, McEwen BS, Epel ES, Sandi C. An energetic view of stress: focus on mitochondria. Front Neuroendocrinol. 2018;49:72–85.
pubmed: 29339091
pmcid: 5964020
doi: 10.1016/j.yfrne.2018.01.001
Mandelker L. Introduction to oxidative stress and mitochondrial dysfunction. Vet Clin North Am Small Anim Pract. 2008;38(1–30):v.
Morris G, Walder KR, Berk M, Marx W, Walker AJ, Maes M, et al. The interplay between oxidative stress and bioenergetic failure in neuropsychiatric illnesses: can we explain it and can we treat it? Mol Biol Rep. 2020;47:5587–620.
pubmed: 32564227
doi: 10.1007/s11033-020-05590-5
Alsop D, Vijayan MM, American Physiological Society. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am J Physiol Regul Integr Comp Physiol. 2008;294:R711–9.
pubmed: 18077507
doi: 10.1152/ajpregu.00671.2007
de Abreu MS, Koakoski G, Ferreira D, Oliveira TA, da Rosa JGS, Gusso D, et al. Diazepam and fluoxetine decrease the stress response in zebrafish. PLoS ONE. 2014;9:e103232.
pubmed: 25054216
pmcid: 4108411
doi: 10.1371/journal.pone.0103232
Bertelli PR, Mocelin R, Marcon M, Sachett A, Gomez R, Rosa AR, et al. Anti-stress effects of the glucagon-like peptide-1 receptor agonist liraglutide in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111: 110388.
pubmed: 34147534
doi: 10.1016/j.pnpbp.2021.110388
Champagne DL, Hoefnagels CCM, de Kloet RE, Richardson MK. Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res. 2010;214:332–42.
pubmed: 20540966
doi: 10.1016/j.bbr.2010.06.001
Dal Santo G, Conterato GMM, Barcellos LJG, Rosemberg DB, Piato AL. Acute restraint stress induces an imbalance in the oxidative status of the zebrafish brain. Neurosci Lett. 2014;558:103–8.
doi: 10.1016/j.neulet.2013.11.011
Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res. 2009;205:38–44.
pubmed: 19540270
pmcid: 2922906
doi: 10.1016/j.bbr.2009.06.022
Fontana BD, Cleal M, Gibbon AJ, McBride SD, Parker MO. The effects of two stressors on working memory and cognitive flexibility in zebrafish (Danio rerio): the protective role of D1/D5 agonist on stress responses. Neuropharmacology. 2021;196: 108681.
pubmed: 34175323
doi: 10.1016/j.neuropharm.2021.108681
Ghisleni G, Capiotti KM, Da Silva RS, Oses JP, Piato ÂL, Soares V, et al. The role of CRH in behavioral responses to acute restraint stress in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry. 2012;36:176–82.
pubmed: 21893154
doi: 10.1016/j.pnpbp.2011.08.016
Giacomini ACVV, Abreu MS, Giacomini LV, Siebel AM, Zimerman FF, Rambo CL, et al. Fluoxetine and diazepam acutely modulate stress induced-behavior. Behav Brain Res. 2016;296:301–10.
pubmed: 26403161
doi: 10.1016/j.bbr.2015.09.027
Idalencio R, Kalichak F, Rosa JGS, de Oliveira TA, Koakoski G, Gusso D, et al. Waterborne risperidone decreases stress response in zebrafish. PLoS ONE. 2015;10:e0140800 (Public Library of Science).
pubmed: 26473477
pmcid: 4608780
doi: 10.1371/journal.pone.0140800
Mocelin R, Herrmann AP, Marcon M, Rambo CL, Rohden A, Bevilaqua F, et al. N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish. Pharmacol Biochem Behav. 2015;139:121–6.
pubmed: 26261019
doi: 10.1016/j.pbb.2015.08.006
Pancotto L, Mocelin R, Marcon M, Herrmann AP, Piato A. Anxiolytic and anti-stress effects of acute administration of acetyl-L-carnitine in zebrafish. PeerJ. 2018;6:e5309.
pubmed: 30083453
pmcid: 6074796
doi: 10.7717/peerj.5309
Piato AL, Rosemberg DB, Capiotti KM, Siebel AM, Herrmann AP, Ghisleni G, et al. Acute restraint stress in zebrafish: behavioral parameters and purinergic signaling. Neurochem Res. 2011;36:1876–86.
pubmed: 21603935
doi: 10.1007/s11064-011-0509-z
Reis CG, Mocelin R, Benvenutti R, Marcon M, Sachett A, Herrmann AP, et al. Effects of N-acetylcysteine amide on anxiety and stress behavior in zebrafish. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:591–601.
pubmed: 31768573
doi: 10.1007/s00210-019-01762-8
da Silva Marques JG, Antunes FTT, da Silva Brum LF, Pedron C, de Oliveira IB, de Barros Falcão Ferraz A, et al. Adaptogenic effects of curcumin on depression induced by moderate and unpredictable chronic stress in mice. Behav Brain Res. 2021;399:113002.
pubmed: 33161033
doi: 10.1016/j.bbr.2020.113002
Khodadadegan MA, Azami S, Guest PC, Jamialahmadi T, Sahebkar A. Effects of curcumin on depression and anxiety: a narrative review of the recent clinical data. Adv Exp Med Biol. 2021;1291:283–94.
pubmed: 34331697
doi: 10.1007/978-3-030-56153-6_17
Lopresti AL, Maes M, Maker GL, Hood SD, Drummond PD. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. J Affect Disord. 2014;167:368–75.
pubmed: 25046624
doi: 10.1016/j.jad.2014.06.001
Matias JN, Achete G, Campanari GSDS, Guiguer ÉL, Araújo AC, Buglio DS, et al. A systematic review of the antidepressant effects of curcumin: beyond monoamines theory. Aust N Z J Psychiatry. 2021;55:451–62.
pubmed: 33673739
doi: 10.1177/0004867421998795
Mohammad Abu-Taweel G, Al-Fifi Z. Protective effects of curcumin towards anxiety and depression-like behaviors induced mercury chloride. Saudi J Biol Sci. 2021;28:125–34.
pubmed: 33424289
doi: 10.1016/j.sjbs.2020.09.011
Yang K-Y, Lin L-C, Tseng T-Y, Wang S-C, Tsai T-H. Oral bioavailability of curcumin in rat and the herbal analysis from curcuma longa by LC–MS/MS. J Chromatogr B. 2007;853:183–9.
doi: 10.1016/j.jchromb.2007.03.010
Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–18.
pubmed: 17999464
doi: 10.1021/mp700113r
Almeida ER, Lima-Rezende CA, Schneider SE, Garbinato C, Pedroso J, Decui L, et al. Micronized resveratrol shows anticonvulsant properties in pentylenetetrazole-induced seizure model in adult zebrafish. Neurochem Res. 2021;46:241–51.
pubmed: 33108629
doi: 10.1007/s11064-020-03158-0
Decui L, Garbinato CLL, Schneider SE, Mazon SC, Almeida ER, Aguiar GPS, et al. Micronized resveratrol shows promising effects in a seizure model in zebrafish and signalizes an important advance in epilepsy treatment. Epilepsy Res. 2020;159: 106243.
pubmed: 31786493
doi: 10.1016/j.eplepsyres.2019.106243
Sachett A, Gallas-Lopes M, Benvenutti R, Marcon M, Aguiar GPS, Herrmann AP, et al. Curcumin micronization by supercritical fluid: In vitro and in vivo biological relevance. Ind Crops Prod. 2022;177: 114501.
doi: 10.1016/j.indcrop.2021.114501
du Sert NP, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Br J Pharmacol. 2020;177:3617–24.
doi: 10.1111/bph.15193
Leary S, Underwood W, Anthony R, Cartner S, Grandin T, Greenacre C, et al. AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. Schaumburg, Ill: AVMA, 2020. https://www.avma.org/sites/default/files/2020-02/Guidelines-on-Euthanasia-2020.pdf
Benvenutti R, Gallas-Lopes M, Sachett A, Marcon M, Strogulski NR, Reis CG, et al. How do zebrafish (Danio rerio) respond to MK-801 and amphetamine? Relevance for assessing schizophrenia-related endophenotypes in alternative model organisms. J Neurosci Res. 2021. https://doi.org/10.1002/jnr.24948 .
doi: 10.1002/jnr.24948
pubmed: 34496062
Sachett A. How to prepare zebrafish brain tissue samples for biochemical assays. 2020 [cited 2021 Aug 4]. Available from: https://www.protocols.io/view/how-to-prepare-zebrafish-brain-tissue-samples-for-bjkdkks6
Sachett A. Protein quantification protocol optimized for zebrafish brain tissue (Bradford method). 2020 [cited 2021 Aug 4]. Available from: https://www.protocols.io/view/optimized-protein-quantification-bradford-protocol-bjnfkmbn
Sachett A, Gallas-Lopes M, Conterato GMM, Radharani, Herrmann A, Piato A. Quantification of nonprotein sulfhydryl groups (NPSH) optimized for zebrafish brain tissue [Internet]. protocols.io. 2021 [cited 2021 Oct 11]. Available from: https://www.protocols.io/view/quantification-of-nonprotein-sulfhydryl-groups-nps-bx8tprwn
Sachett A. Quantification of thiobarbituric acid reactive species (TBARS) optimized for zebrafish brain tissue. 2020 [cited 2021 Aug 4]. Available from: https://www.protocols.io/view/optimized-quantification-of-thiobarbituric-acid-re-bjp8kmrw
Haider S, Naqvi F, Batool Z, Tabassum S, Sadir S, Liaquat L, et al. Pretreatment with curcumin attenuates anxiety while strengthens memory performance after one short stress experience in male rats. Brain Res Bull. 2015;115:1–8.
pubmed: 25869755
doi: 10.1016/j.brainresbull.2015.04.001
Johnson A, Hamilton TJ. Modafinil decreases anxiety-like behaviour in zebrafish. PeerJ. 2017;5: e2994.
pubmed: 28229024
pmcid: 5312568
doi: 10.7717/peerj.2994
Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology. 2012;62:135–43.
pubmed: 21843537
doi: 10.1016/j.neuropharm.2011.07.037
McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav. 2003;43:2–15.
pubmed: 12614627
doi: 10.1016/S0018-506X(02)00024-7
Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7:65–74.
pubmed: 19721819
pmcid: 2724665
doi: 10.2174/157015909787602823
Gilhotra N, Dhingra D. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice. Brain Res. 2010;1352:167–75.
pubmed: 20633542
doi: 10.1016/j.brainres.2010.07.007
Ceremuga TE, Helmrick K, Kufahl Z, Kelley J, Keller B, Philippe F, et al. Investigation of the anxiolytic and antidepressant effects of curcumin, a compound from turmeric (curcuma longa), in the adult male Sprague-Dawley rat. Holist Nurs Pract. 2017;31:193–203.
pubmed: 28406873
doi: 10.1097/HNP.0000000000000208
Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA, American Chemical Society. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60:1620–37.
pubmed: 28074653
pmcid: 5346970
doi: 10.1021/acs.jmedchem.6b00975